4.4 Article

Nurr1 downregulation is caused by CREB inactivation in a Parkinson's disease mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1

Yongwoo Jang et al.

Summary: Recent studies have shown that the ligand-binding pocket of Nurr1 is highly dynamic, allowing for conformational changes on a microsecond-to-millisecond timescale. This flexibility suggests that certain ligands may induce a change in the structure to create an accessible cavity. The cocrystallographic structure of Nurr1 bound to endogenous ligands has helped clarify the crucial roles of Nurr1 and pave the way for potential therapeutic interventions in Nurr1-related diseases.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Neurosciences

α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism

Congcong Jia et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Article Biotechnology & Applied Microbiology

Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model

Congcong Sun et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Editorial Material Multidisciplinary Sciences

Toward neuroprotective treatments of Parkinson's disease

Kwang-Soo Kim

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Neurosciences

Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology

Carlos A. Saura et al.

TRENDS IN NEUROSCIENCES (2017)

Review Neurosciences

Nurr1-Based Therapies for Parkinson's Disease

Jie Dong et al.

CNS NEUROSCIENCE & THERAPEUTICS (2016)

Article Medicine, Research & Experimental

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease

Sang-Min Oh et al.

EMBO MOLECULAR MEDICINE (2015)

Review Clinical Neurology

NURR1 in Parkinson disease-from pathogenesis to therapeutic potential

Mickael Decressac et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Cell Biology

α-Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons

Mickael Decressac et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Review Biochemistry & Molecular Biology

CREB: a multifaceted regulator of neuronal plasticity and protection

Kensuke Sakamoto et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function

L. M. Valor et al.

CELL DEATH AND DIFFERENTIATION (2010)

Article Multidisciplinary Sciences

NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection

Nikolaos Volakakis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Neurosciences

Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons

Banafsheh Kadkhodaei et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

Anamitra Ghosh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells

Elisabeth M. Chalovich et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Neurosciences

Nurr1 in Parkinson's disease and related disorders

YP Chu et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2006)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Article Genetics & Heredity

Disruption of CREB function in brain leads to neurodegeneration

T Mantamadiotis et al.

NATURE GENETICS (2002)

Review Biochemistry & Molecular Biology

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

S Przedborski et al.

JOURNAL OF NEUROCHEMISTRY (2001)